Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-08-04

Clinical Trial Update: Earlier Triggering in Rec-FSH/GnRH Antagonist Cycles [Phase 2, Phase 3]

View source ↗

Summary

This document reports results from Phase 2 and Phase 3 trials evaluating earlier triggering in cycles using recombinant FSH and a GnRH antagonist with hCG in as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetrorelix (Cetrorelix acetate)
  • Human chorionic gonadotropin (human chorionic gonadotropin)
  • recombinant FSH (follicle-stimulating hormone)

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: hCG | Phase 2, Phase 3 | Status: COMPLETED